Haemophilia: Medical Treatments

Department of Health and Social Care written question – answered on 6th November 2018.

Alert me about debates like this

Photo of Jim Shannon Jim Shannon Shadow DUP Spokesperson (Human Rights), Shadow DUP Spokesperson (Health)

To ask the Secretary of State for Health and Social Care, with reference to Trigger 1 of NHS England’s Specialised Commissioning Briefing (Spring 2018), how the faster adoption of best value medicines requirement will affect the procurement of Extended Half Life factor VIII products; and which Factor VIII blood products will be covered by the Commissioning for Quality and Innovation.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

I refer the hon. Member to the answer I gave on 4 September 2018 to Question 167279.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.